These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19811509)

  • 41. How early can one diagnose Cushing's disease? An early diagnosis in a case of prepubertal Cushing's disease.
    Hoppmann J; Wagner IV; Junghans G; Wudy SA; Buchfelder M; Hirsch FW; Ritter L; Kiess W; Pfäffle R
    J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1043-7. PubMed ID: 25367688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
    Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CRH in Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of bilateral inferior petrosal sinus sampling in the diagnosis and surgical treatment of the ACTH-dependent Cushing's syndrome: a comparison with other tests.
    Shi X; Sun Q; Bian L; Zhao W; Shen J; Wang W; Ning G
    Neuro Endocrinol Lett; 2011; 32(6):865-73. PubMed ID: 22286783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The differential diagnosis of Cushing's syndrome.
    Newell-Price J; Grossman AB
    Ann Endocrinol (Paris); 2001 Apr; 62(2):173-9. PubMed ID: 11353890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Newell-Price J; Morris DG; Drake WM; Korbonits M; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1640-5. PubMed ID: 11932295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multihormonal response to corticotropin-releasing hormone in inferior petrosal sinus blood of patients with Cushing's disease.
    Allolio B; Günther RW; Benker G; Reinwein D; Winkelmann W; Schulte HM
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1195-201. PubMed ID: 1699962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
    Avgerinos PC; Chrousos GP; Nieman LK; Oldfield EH; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1987 Nov; 65(5):906-13. PubMed ID: 3499448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Central venous sampling and magnetic resonance imaging in the diagnosis of ACTH-dependent Cushing's syndrome.
    Aydoğan Ünsal Y; Öz Gül Ö; Ateş C; Aydemir E; Cander S; Ersoy C; Özpar R; Hakyemez B; Ertürk E
    Neuroradiol J; 2023 Jun; 36(3):341-345. PubMed ID: 36074996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test.
    Ritzel K; Beuschlein F; Berr C; Osswald A; Reisch N; Bidlingmaier M; Schneider H; Honegger J; Geyer LL; Schopohl J; Reincke M
    Eur J Endocrinol; 2015 Aug; 173(2):197-204. PubMed ID: 25953828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultra-high field magnetic resonance imaging for localization of corticotropin-secreting pituitary adenomas.
    Patel V; Liu CJ; Shiroishi MS; Hurth K; Carmichael JD; Zada G; Toga AW
    Neuroradiology; 2020 Aug; 62(8):1051-1054. PubMed ID: 32306052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-resolution contrast-enhanced MRI with three-dimensional fast spin echo improved the diagnostic performance for identifying pituitary microadenomas in Cushing's syndrome.
    Liu Z; Hou B; You H; Lu L; Duan L; Li M; Deng K; Yao Y; Zhu H; Feng F
    Eur Radiol; 2023 Sep; 33(9):5984-5992. PubMed ID: 37212846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of three-Tesla magnetic resonance imaging for the identification of pituitary adenoma in patients with Cushing's disease.
    Fukuhara N; Inoshita N; Yamaguchi-Okada M; Tatsushima K; Takeshita A; Ito J; Takeuchi Y; Yamada S; Nishioka H
    Endocr J; 2019 Mar; 66(3):259-264. PubMed ID: 30760659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Responses to corticotrophin-releasing hormone and dexamethasone in a large series of human adrenocorticotrophic hormone-secreting pituitary adenomas in vitro reveal manifold corticotroph tumoural phenotypes.
    Pecori Giraldi F; Pagliardini L; Cassarino MF; Losa M; Lasio G; Cavagnini F
    J Neuroendocrinol; 2011 Dec; 23(12):1214-21. PubMed ID: 21883533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.